Full-Time

Global Regulatory Lead

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: Bridgewater Township, NJ, USA

Hybrid position.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • At least 12+ years of relevant pharmaceutical/biotechnology experience in R&D, including at least 10 years of relevant Regulatory Affairs experience (regionally and/or global), in early and late development
  • Proven record of leading filing/registrations and obtaining regulatory action in major market(s)
  • Demonstrated expert regulatory strategic experience and understanding of the regulatory environment to develop regulatory strategies
  • Experience being accountable for developing and defending innovative regulatory strategies at Global Project Teams or equivalent forum
  • Proven track record of developing innovative regulatory strategies supporting the clinical development of drugs and/or innovative biologics products
  • BS/BA degree in a relevant scientific discipline required
  • Advanced degree (PharmD, PhD, MD or DVM or MSc in Biology, Life Science, or related field) is preferred.
Responsibilities
  • As Global Regulatory Affairs Lead (GRL), you will be the fully accountable decision maker for the development & execution of creative, thoughtful, and robust global regulatory strategies for your products in Sanofi’s diversified portfolio in order to meet corporate and business objectives.
  • You will be the primary interface and key strategic GRA partner for the Global Project Team (GPT) and Global Brand Team (GBT).
  • Accountable for leading the development and execution of innovative and value-added global regulatory strategies and responsible for formulating the Global Regulatory Project Strategy (GRPS), Global Submission Strategy, and core product labeling in development as well as for life cycle management of products.
  • Responsible for proactively contributing to the Target Product Profile (TPP), ensuring competitive profiles in alignment with the business objectives.
  • Accountable for leading the GRT for fostering team performance by aligning team on mission, prioritization, objectives and setting clear expectations for the Global Regulatory Strategy and Plan, including a global labeling strategy for assigned projects.
  • Supervise, coach, and facilitate a feedback culture within the GRT to develop team performance.
  • Develop a team of Regulatory Strategists (RS) as appropriate.
  • Accountable for ensuring alignment and communication internally and externally as 'one GRA voice' with TA, GBU Head and up to the GRA LT when needed to advocate regulatory position to governance and committees and shares outcomes to GRT and cross-functional partners as appropriate.
  • Identify opportunities to support the team to identify regulatory acceleration opportunities, take thoughtful risks, accept challenges, and making final decisions on the regulatory success rates and mitigations on behalf of the GRT.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?